CytoAurora Wins CES 2026 Innovation Awards Honoree in the Digital Health Category
CytoAurora Wins CES 2026 Innovation Awards Honoree in the Digital Health Category at CES 2026 in Las Vegas, USA, held from January 6–9, 2026, CytoAurora received the Innovation Awards Honoree in the Digital Health category for its Nano CAST Cancer Solution.
Under the leadership of Dr. Kich Aungvitulsatit, Executive of CytoAurora Biotechnology (Thailand) Co., Ltd., the company aims to make advanced cancer screening technology accessible to the Thai population.
This achievement is the result of integrating semiconductor technology with artificial intelligence (AI), developing a cancer cell analysis system that is both fast and highly accurate. Notably, in 2026, CytoAurora Biotechnology was the only team from Taiwan to receive this prestigious award in the category.
In addition to our success at CES, CytoAurora was honored by the Seoul Business Agency (SBA) to represent Thailand at the Global Innovation Forum 2026 (GIF 2026), joining leading research teams from around the world. This further reinforces our position as a globally recognized leader in single-cell technology.
Read more : https://shorturl.asia/sCcOp